Federal protections promise a fair trial in a language you understand, but for millions who speak lesser-known languages, ...

Oral presentation at JDA features new data from the KT-621 Phase 1 study in healthy Japanese adults, with safety and PK/PD results consistent ...

At the RP2D and maximum tolerated dose (100 µg,) cemsidomide achieved a 53% overall response rate (ORR). At the 75 µg dose level, cemsidomide achieved a 40% ORR. Across all doses evaluated, ...

Sequoyah’s syllabary faced suspicion initially, but after a demonstration, his version of “talking leaves” was widely ...

PSMA PET has become central to prostate cancer imaging as advanced disease incidence rises and prostate-specific membrane ...

Scribe Therapeutics, Inc. (Scribe), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and ...

Ben Lerner’s fourth novel, Transcription, starts off like an anxiety dream. Its unnamed narrator is interviewing his mentor, a renowned artist and scholar called Thomas, but has accidentally dropped ...

“As ever with Ben Lerner’s novels, the plot of Transcription is sparse, propelled mostly by the characters’ winding speech and the narrator’s thoughts,” said Hannah Gold in Harper’s. But even at 144 ...

As we scroll through the final portion of human history before it gets permanently revised by AI, Ben Lerner has written a lyrical novel of loss. As in his previous autofictional trilogy, Lerner uses ...

Let’s hazard an assertion: On or about June 2007, human character changed. To be more exact—because the phrase human character now feels antique—we might say instead that the human sensorium changed.

With “Transcription,” the writer makes a case for the vitality of the form. By Parul Sehgal Although the exact dates remain hazy, I think it is safe to say that sometime between 2009 and 2014 it ...